Impact of tranexamic acid on bleeding during coronary artery bypass for patients under treatment of low molecular weight heparin
Aim: Tranexamic acid (TA) is an antifibrinolytic agent that prevents the dissolution of fibrin clot. We investigated the impact of the use of tranexamic acid (TA) on bleeding for patients under treatment of low molecular weight heparin during coronary artery bypass graft (CABG) operations. Methods:...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Journal of Surgery and Medicine
2020-04-01
|
Series: | Journal of Surgery and Medicine |
Subjects: | |
Online Access: | https://dergipark.org.tr/en/pub/josam/issue/53710/713471 |